General MedicationsINTRAVENOUSGeneric
VASOSTRICT
VASOPRESSIN
Standard Dose
50UNITS/50ML (1UNITS/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Discontinued
Summary
Approval overview VASOSTRICT is listed in Drugs@FDA under application 204485 (NDA).
Review priority: N/A Marketing status: Discontinued Active ingredient VASOPRESSIN Form and strength SOLUTION;INTRAVENOUS - 50UNITS/50ML (1UNITS/ML) Sponsor PH HEALTH Submission history Latest submission status date: 2023-04-12 00:00:00.
Structured Monograph
Clinical summary
Approval overview VASOSTRICT is listed in Drugs@FDA under application 204485 (NDA). Review priority: N/A Marketing status: Discontinued Active ingredient VASOPRESSIN Form and strength SOLUTION;INTRAVENOUS - 50UNITS/50ML (1UNITS/ML) Sponsor PH HEALTH Submission history Latest submission status date: 2023-04-12 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: N/A
Interaction Notes
- No interaction notes stored yet.